RA
Red Arrow Therapeutics develops novel cancer therapies by transforming proinflammatory biology using proprietary nanopolymer drug delivery technology. The company focuses on pioneering the Interleukin-12 prodrug Axis to create safe and effective solutions for patients. Their platform technology is broadly applicable across various molecular targets for next-generation biopharmaceutical delivery.
Updated 4 months ago
Funding
$5.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Red Arrow Therapeutics develops novel cancer therapies by transforming proinflammatory biology using proprietary nanopolymer drug delivery technology. The company focuses on pioneering the Interleukin-12 prodrug Axis to create safe and effective solutions for patients. Their platform technology is broadly applicable across various molecular targets for next-generation biopharmaceutical delivery.